Report Content
Chapter 1 Methodology
1.1 Industry coverage
1.2 Market scope & definitions
1.3 Base estimates & working
1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact at global level
1.6 Data validation
1.7 Data sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Medical device testing services industry 3600 synopsis, 2018 - 2032
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Services trends
2.1.4 Phase trends
Chapter 3 Medical Device Testing Services Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing focus on strict approval norms
3.2.1.2 Consistent and rapid advancements in medical technologies
3.2.1.3 Rising need for verification and validation of medical devices
3.2.2 Industry pitfalls & challenges
3.2.2.1 Lack of skilled professionals and testing facilities
3.2.2.2 Disparity in legal and regulatory issues
3.3 Growth potential analysis
3.3.1 By services
3.3.2 By phase
3.4 COVID-19 impact analysis
3.5 Regulatory landscape
3.6 Technology advancements
3.7 Future market trends
3.8 Policy landscape
3.9 Porter’s analysis
3.10 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive positioning matrix
4.4 Vendor matrix analysis
4.5 Company share analysis, 2022
4.6 Strategy dashboard, 2022
Chapter 5 Medical Device Testing Services Market Size and Forecast, By Services (USD Million)
5.1 Key services trends
5.2 Biocompatibility tests
5.3 Chemistry test
5.4 Microbiology & sterility testing
5.5 Package validation
Chapter 6 Medical Device Testing Services Market Size and Forecast, By Phase (USD Million)
6.1 Key phase trends
6.2 Preclinical
6.3 Clinical
Chapter 7 Medical Device Testing Services Market Size and Forecast, By Region (USD Million)
7.1 Key regional trends
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 France
7.3.4 Spain
7.3.5 Italy
7.3.6 Poland
7.3.7 Sweden
7.3.8 The Netherlands
7.4 Asia Pacific
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Australia
7.4.5 South Korea
7.4.6 Indonesia
7.4.7 Philippines
7.4.8 Vietnam
7.5 Latin America
7.5.1 Brazil
7.5.2 Mexico
7.5.3 Argentina
7.5.4 Columbia
7.5.5 Chile
7.5.6 Peru
7.6 MEA
7.6.1 South Africa
7.6.2 Saudi Arabia
7.6.3 UAE
7.6.4 Turkey
7.6.5 Israel
7.6.6 Iran
Chapter 8 Company Profiles
8.1 Charles River Laboratories
8.2 Eurofins Scientific
8.3 SGS S.A.
8.4 Labcorp (Toxikon, Inc)
8.5 American Preclinical Services
8.6 Intertek Group Plc.
8.7 North America Science Associates Inc.
8.8 Element Materials Technology
8.9 WuXiAppTec Group
8.10 TÜV SÜD AG
8.11 Pace Analytical Services, LLC
8.12 Sterigenics International LLC
